REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc., a world leader in genomic diagnostics for infectious disease, today announced it has secured $100 million in Series C funding. The round was ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc., a leader in genomic diagnostics for infectious diseases, announced today that the Karius Test® has been granted designation as a Breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results